Table 3. Number of patients exceeding cut off points for tPSA, f/tPSA ratio, and cPSA before and after ejaculation.
| tPSA>2.5 ng/mL | fPSA/tPSA<0.25 | cPSA>2.3 ng/mL | ||||
|---|---|---|---|---|---|---|
| Study Group (n=62) n (%) | Control Group (n=36) n (%) | Study Group (n=62) n (%) | Control Group (n=36) n (%) | Study Group (n=62) n (%) | Control Group (n=36) n (%) | |
| Before | 26 (41.9) | 23 (63.9) | 15 (24.2) | 14 (38.9) | 22 (35.5) | 17 (42.7) |
| 1. hour | 26 (41.9) | 23 (63.9) | 13 (20.9) | 13 (36.1) | 22 (35.5) | 18 (50.0) |
| 5. hour | 27 (43.5) | 23 (63.9) | 11 (17.7) | 14 (38.9) | 22 (35.5) | 16 (44.4) |
| 24. hour | 27 (43.5) | 22 (61.1) | 10 (16.1) | 15 (41.7) | 23 (37.1) | 17 (42.7) |
| 72. hour | 26 (41.9) | 23 (63.9) | 11 (17.7) | 15 (41.7) | 23 (37.1) | 17 (42.7) |
| *p | 0.480 †/‡/§;1.000 ¶ | 0.480 †/¶; 0.617 ‡/§ | 0.617 †/‡; 1.000 §/¶ | 0.480 †/‡/§/¶ | 0.480 †/‡/§/¶ | 0.480 †/‡/§/¶ |
*McNemar’s test; †basal vs. 1hour; ‡basal vs. 5hour; §basal vs. 24hours; ¶ basal vs. 72hours (tPSA=total prostate-specific antigen; fPSA=free PSA; cPSA=complexed PSA)